Despite the significant impact migraines can have on daily life, a surprising number of people hesitate to seek medical attention. A recent study revealed that nearly a third of migraine
News & Updates
Let's delve into the concerning underdiagnosis of iron deficiency, particularly nonanemic iron deficiency (NAID), in women. The Barton et al. study examined a large cohort of women in the US
Long COVID, a debilitating condition marked by persistent symptoms following a COVID-19 infection, impacts millions globally. Yet, research towards effective treatments faces a significant hurdle: recruiting participants for clinical trials.
A study by Orsolya Kiss, PhD, a research scientist at SRI International, investigated how sleep duration, social media use, and brain activity interact in adolescents. The findings suggest a complex
Beckman Coulter, a leading clinical diagnostics company, announced the U.S. Food and Drug Administration (FDA) clearance of its Access NT-proBNP assay. This new test aids in diagnosing heart failure and
Diving into the exciting world of pharmacogenomics (PGx), a field that utilizes genetic testing to understand how an individual's genes influence their response to medications.
Delving into the ongoing debate surrounding calcium and its potential link to an increased risk of cardiovascular disease (CVD), particularly when consumed through supplements.
Venture capital firms are the lifeblood of many biotech startups, providing not only vital financial resources but also operational expertise. This article dives into ten prominent venture capital arms established
A new report by the Expert Group on Future Skills Needs (EGFSN) predicts significant growth in Ireland's biopharmaceutical industry. The report, titled "Skills for Biopharma," estimates the creation of 21,000-26,000
The European Medicines Agency (EMA) has released a revised question-and-answer document to aid manufacturers, regulators, and notified bodies involved with medical devices used alongside medications. This document offers practical guidance
Researchers are exploring a novel approach combining a genetically modified herpes virus with a cancer vaccine. This combination therapy holds promise for treating aggressive childhood cancer.
Bayer presented promising data from their Phase III OASIS clinical trials on Elinzanetant, a potential new weapon in the fight against hot flashes and other menopause symptoms. Elinzanetant is a